Litcius/Paper detail

Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines

Carlos A. Gongora, Zsófia D. Drobni, Thiago Quinaglia Araujo Costa Silva, Amna Zafar, Jingyi Gong, Daniel A. Zlotoff, Hannah Gilman, Sarah Hartmann, Supraja Sama, Sofia Nikolaidou, Giselle Alexandra Suero‐Abreu, Eric N. Jacobsen, Jeremy S. Abramson, Ephraim P. Hochberg, J. R. Barnes, Philippe Armand, Paaladinesh Thavendiranathan, Anju Nohria, Tomas G. Neilan

2022JACC Heart Failure155 citationsDOIOpen Access PDF

Topics & Concepts

MedicineHeart failureInternal medicineEjection fractionCardiotoxicityCardiomyopathyCancerIncidence (geometry)Diabetes mellitusCardiologyChemotherapyEndocrinologyOpticsPhysicsDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerChemotherapy-induced cardiotoxicity and mitigation
Sodium-Glucose Co-Transporter-2 Inhibitors and Cardiac Outcomes Among Patients Treated With Anthracyclines | Litcius